ArticleAntimicrobial agents and chemotherapy2019
Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in
Open access · bronzeAbstract readMulticenter Study
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.
0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed, 71 citations in OpenAlex.
- Performance of the Sensititre YeastOne assay compared with EUCAST E.Def 9.4 againstJAC-antimicrobial resistance · 2026Article
- Evolution of Candidaemia and azole resistance in Italy: A multicentre retrospective study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Clinical Characteristics and Mortality Risk Factors ofAnnals of laboratory medicine · 2026Article
- Head-to-Head Comparison of Etest, MICRONAUT-AM EUCAST and Reference Broth Microdilution-Based CLSI Results forJournal of fungi (Basel, Switzerland) · 2025Article
- Susceptibility patterns ofInfection prevention in practice · 2024Article
- Evaluation of Etest and MICRONAUT-AM Assay for Antifungal Susceptibility Testing ofAntibiotics (Basel, Switzerland) · 2024Article
- Implication of genotypes for prognosis of Candida glabrata bloodstream infections.The Journal of antimicrobial chemotherapy · 2024Article
- Commercial Methods for Antifungal Susceptibility Testing of Saprophytic Molds: Can They Be Used to Detect Resistance?Journal of fungi (Basel, Switzerland) · 2024Review
- First Report of the Emerging PathogenJournal of fungi (Basel, Switzerland) · 2024Article
- Oral Candida carriage and resistance against common antifungal agents in hematopoietic stem cell transplantation recipients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- Antifungal susceptibility profile and local epidemiological cut-off values ofMicrobiology spectrum · 2024Article
- Surveillance of Amphotericin B and Azole Resistance inJournal of fungi (Basel, Switzerland) · 2023Article
- Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation.Microbiology spectrum · 2023Article
- Article
- Yeast Bloodstream Infections in the COVID-19 Patient: A Multicenter Italian Study (FiCoV Study).Journal of fungi (Basel, Switzerland) · 2023Article
- Article
- Article
- Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11.BMC microbiology · 2022Article
- Commercial Methods for Antifungal Susceptibility Testing of Yeasts: Strengths and Limitations as Predictors of Resistance.Journal of fungi (Basel, Switzerland) · 2022Review
- Increasing Incidence and Shifting Epidemiology of Candidemia in Greece: Results from the First Nationwide 10-Year Survey.Journal of fungi (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
43 authors at 20 institutions in 15 countries.
A Espinel-IngroffVCU Medical Center, Richmond, Virginia, USA victoria.ingroff@vcuhealth.org.
J TurnidgeUniversity of Adelaide, Adelaide, Australia.
A Alastruey-IzquierdoMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.ORCID 0000-0001-8651-4405
F BotterelUnité de Parasitologie, Mycologie, Département de Bactériologie Virologie Hygiène Mycologie Parasitologie, Créteil, France.
E CantonGrupo de Infección Grave, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
C CastroUnidad de Gestión Clínica de Enfermedades Infecciosas y Microbiología Hospital de Valme, Seville, Spain.
Y-C ChenDepartment of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
Y ChenPublic Health Ontario, Toronto, Ontario, Canada.
E ChryssanthouKlinisk Mikrobiologi, Karolinska Universitetlaboratoriet, Karolinska Universitetssjukhuset, Stockholm, Sweden.
E DannaouiUniversité Paris-Descartes, Faculté de Médecine, APHP, Hôpital Européen Georges Pompidou, Unité de Parasitologie-Mycologie, Service de Microbiologie, Paris, France.ORCID 0000-0002-2817-3830
G Garcia-EffronLaboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Santa Fe, Argentina.
G M GonzalezUniversidad Autónoma de Nuevo León, Nuevo León, Mexico.
N P GovenderNational Institute for Communicable Diseases (Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses), a division of the National Health Laboratory Service and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.ORCID 0000-0001-7869-9462
J GuineaHospital General Universitario Gregorio Marañón, Madrid, Spain.ORCID 0000-0002-7901-8355
S KiddSA Pathology National Mycology Reference Centre, Adelaide, Australia.
M LacknerDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
C Lass-FlörlDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
M J Linares-SiciliaDepartamento de Microbiología, Facultad de Medicina y Enfermería, Universidad de Córdoba, Córdoba, Spain.
L López-SoriaHospital Universitario Cruces, Barakaldo, Spain.
R MagoboUniversité Paris-Descartes, Faculté de Médecine, APHP, Hôpital Européen Georges Pompidou, Unité de Parasitologie-Mycologie, Service de Microbiologie, Paris, France.
T PelaezHospital Universitario Central de Asturias (HUCA), Fundación para la Investigación Biomédica y la Innovación Biosanitaria del Principado de Asturias (FINBA), Asturias, Spain.
G QuindósUniversidad del País Vasco/Euskal Herriko Unibertsitatea, UPV/EHU, Bilbao, Spain.ORCID 0000-0003-0438-2248
M A Rodriguez-IglesiaDepartamento de Biomedicina Biotecnología y Salud Pública, Universidad de Cádiz, Cadiz, Spain.
M A RuizIIS Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain.
F Sánchez-ReusHospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID 0000-0002-6800-5487
M SanguinettiInstitute of Microbiology, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID 0000-0002-9780-7059
R ShieldsUniversity of Pittsburgh, Pittsburgh, Pennsylvania, USA.
P SzwedaDepartment of Pharmaceutical Technology and Biochemistry Faculty of Chemistry, Gdańsk University of Technology, Gdańsk, Poland.ORCID 0000-0001-8291-5148
A TortoranoDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0003-2093-8250
N L WengenackMayo Clinic Rochester, Rochester, Minnesota, USA.
S BramatiMicrobiology Laboratory Ospedale San Gerardo, Monza, Italy.
C CavannaMicrobiology and Virology Unit IRCCS Policlinico, San Matteo, Pavia, Italy.
C DeLucaMicrobiology Section, Humanitas Research Hospital, Milan, Italy.
M GelmiMicrobiology Laboratory, A.O. Spedali Civili, Brescia, Italy.
A GranciniMicrobiology Laboratory, Fondazione IRCCS Cà Granda O. Maggiore Policlinico, Milan, Italy.
G LombardiMicrobiology Laboratory, Niguarda Hospital, Milan, Italy.
J MeletiadisClinical Microbiology Laboratory, Attikon Hospital Medical School, National and Kapodistrian University of Athens, Athens, Greece.
C E NegriLaboratório Especial de Micologia, Disciplina de Infectologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.
M PasseraMicrobiology Institute, ASST Papa Giovanni XXIII, Bergamo, Italy.
J PemanUnidad de Micología, Servicio de Microbiología, Hospital Universitario La Fe, Valencia, Spain.ORCID 0000-0003-3222-5653
A PrigitanoDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.
E SalaMicrobiology-ASST Lariana, Como, Italy.
M TejadaMedicina di Laboratorio IRCCS Policlinico San Donato, Milan, Italy.
Innsbruck Medical University · ATPublic Health Ontario · CAUniversité Paris Cité · FRUniversity of Milan · ITAzienda Ospedaliera San Gerardo · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITAzienda Socio Sanitaria Territoriale Lariana · ITConsejo Nacional de Investigaciones Científicas y Técnicas · ARFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITGdańsk University of Technology · PLHospital de Cruces · ESHospital de Sant Pau · ESHospital General Universitario Gregorio Marañón · ESHospital Universitari i Politècnic La Fe · ESHospital Universitario de Valme · ESInstituto de Investigación Sanitaria Aragón · ESInstituto de Investigación Sanitaria del Principado de Asturias · ESInstituto de Investigación Sanitaria La Fe · ESInstituto de Salud Carlos III · ES
Funding
Caspofungin pharmacokinetics-pharmacodynamics during intra-adbominal candidiasisK08AI114883 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHIELDS, RYAN K · 2015 to 2019
$858kNIAID NIH HHS K08 AI114883
Abstract
Although the Sensititre Yeast-One (SYO) and Etest methods are widely utilized, interpretive criteria are not available for triazole susceptibility testing of
Indexed as
Antifungal AgentsAspergillosisAspergillusCandidaCandidiasisDisk Diffusion Antimicrobial TestsDrug Resistance, FungalFluconazoleHumansImmunocompromised HostItraconazoleTriazolesVoriconazoleAntifungal AgentsFluconazoleItraconazoleposaconazoleTriazolesVoriconazoleantifungal resistanceAspergillus spp.Candida albicansCandida glabrataEtest method ECVsEtest MICs for fungal mutantsSYO method ECVsSYO MICs for fungal mutantstriazole ECVs
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.